Original Source(s)
Related Content
CKM staging faces an early vascular test
Investigators examined Life’s Essential 8 scores and carotid ultrasonography measures across cardiovascular-kidney-metabolic stages in 1,283 young adults.
September 8, 2026
-
3 min
Tirzepatide’s cardiovascular effects in clinical practice
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
August 28, 2026
-
4 min
FDA Approves First Oral PCSK9 Inhibitor
Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.
July 16, 2026
-
2 min